Marshall E. Cates

1.1k total citations
44 papers, 748 citations indexed

About

Marshall E. Cates is a scholar working on Psychiatry and Mental health, Geriatrics and Gerontology and Clinical Psychology. According to data from OpenAlex, Marshall E. Cates has authored 44 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 11 papers in Geriatrics and Gerontology and 10 papers in Clinical Psychology. Recurrent topics in Marshall E. Cates's work include Pharmaceutical Practices and Patient Outcomes (11 papers), Mental Health Treatment and Access (8 papers) and Schizophrenia research and treatment (5 papers). Marshall E. Cates is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (11 papers), Mental Health Treatment and Access (8 papers) and Schizophrenia research and treatment (5 papers). Marshall E. Cates collaborates with scholars based in United States, Japan and Spain. Marshall E. Cates's co-authors include Thomas W. Woolley, Lori L. Davis, Maisha Kelly Freeman, Cherry W. Jackson, Jacqueline Feldman, Richard E. Powers, Jenny Lam, Anna Palmer, Hiroyuki Kamei and Barbara G. Wells and has published in prestigious journals such as Journal of Clinical Psychopharmacology, Journal of American College Health and Annals of Pharmacotherapy.

In The Last Decade

Marshall E. Cates

41 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marshall E. Cates United States 16 215 192 153 139 136 44 748
Julie A. Dopheide United States 12 229 1.1× 528 2.8× 88 0.6× 194 1.4× 100 0.7× 33 1.0k
Joanne Rodda United Kingdom 12 95 0.4× 401 2.1× 172 1.1× 80 0.6× 71 0.5× 20 1.0k
Heidi J. Wehring United States 21 121 0.6× 484 2.5× 170 1.1× 51 0.4× 185 1.4× 49 1.2k
J. Donoghue United Kingdom 8 90 0.4× 271 1.4× 141 0.9× 212 1.5× 86 0.6× 16 655
Christophe Arbus France 16 207 1.0× 376 2.0× 70 0.5× 93 0.7× 44 0.3× 55 903
Mónica Martínez‐Cengotitabengoa Spain 22 208 1.0× 679 3.5× 91 0.6× 112 0.8× 73 0.5× 49 1.5k
Carmine Munizza Italy 16 384 1.8× 484 2.5× 305 2.0× 245 1.8× 79 0.6× 30 1.3k
Hans Gutzmann Germany 14 120 0.6× 297 1.5× 76 0.5× 48 0.3× 50 0.4× 52 787
Zunera Khan United Kingdom 12 144 0.7× 312 1.6× 71 0.5× 49 0.4× 77 0.6× 25 705
Michael D. Jibson United States 17 280 1.3× 944 4.9× 85 0.6× 98 0.7× 72 0.5× 57 1.5k

Countries citing papers authored by Marshall E. Cates

Since Specialization
Citations

This map shows the geographic impact of Marshall E. Cates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marshall E. Cates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marshall E. Cates more than expected).

Fields of papers citing papers by Marshall E. Cates

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marshall E. Cates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marshall E. Cates. The network helps show where Marshall E. Cates may publish in the future.

Co-authorship network of co-authors of Marshall E. Cates

This figure shows the co-authorship network connecting the top 25 collaborators of Marshall E. Cates. A scholar is included among the top collaborators of Marshall E. Cates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marshall E. Cates. Marshall E. Cates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fargason, Rachel E., Karen L. Gamble, Kristin T. Avis, et al.. (2025). Ramelteon for Insomnia Related to Attention-Deficit/Hyperactivity Disorder (ADHD). Psychopharmacology Bulletin. 44(2). 32–53.
2.
Cates, Marshall E., et al.. (2022). Istradefylline: A novel agent in the treatment of “off” episodes associated with levodopa/carbidopa use in Parkinson disease. Mental Health Clinician. 12(1). 32–36. 15 indexed citations
3.
Harris, Suzanne C., Jolene R. Bostwick, Amy Werremeyer, et al.. (2021). Addressing the Conflict Between Promoting Wellness, Perpetuating Mental Illness Stigma and Making Psychiatric Pharmacy Education Less Intense. American Journal of Pharmaceutical Education. 85(7). 8354–8354. 4 indexed citations
4.
Cates, Marshall E., et al.. (2019). Description of an elective course about mental illness and treatment in the movies. Pharmacy Education. 19(1). 108–115. 2 indexed citations
5.
6.
Cates, Marshall E., et al.. (2017). D-cycloserine in the treatment of posttraumatic stress disorder. Mental Health Clinician. 7(2). 88–94. 16 indexed citations
7.
Cates, Marshall E., et al.. (2017). Effects of focused continuing pharmacy education on pharmacists’ attitudes toward suicide prevention. Pharmacy Education. 17. 12 indexed citations
8.
Dopheide, Julie A., Jolene R. Bostwick, Lisa W. Goldstone, et al.. (2017). Curriculum in Psychiatry and Neurology for Pharmacy Programs. American Journal of Pharmaceutical Education. 81(7). 5925–5925. 26 indexed citations
9.
Cates, Marshall E., et al.. (2015). Sleep Quality Among Pharmacy Students. American Journal of Pharmaceutical Education. 79(1). 9–9. 44 indexed citations
10.
Tanaka, Hiroshi, et al.. (2013). Changes in Attitudes of Japanese Pharmacy Students towards Mental Illness during the didactic portion of the Curriculum. Pharmacy Education. 13. 6 indexed citations
11.
Cates, Marshall E., et al.. (2012). Attitudes of Matriculating First-Year Pharmacy Students Toward a Mandatory, Random Drug-Screening Program. American Journal of Pharmaceutical Education. 76(9). 171–171. 4 indexed citations
12.
Cates, Marshall E. & Michael D. Hogue. (2012). Experience With a Drug Screening Program at a School of Pharmacy. Journal of American College Health. 60(6). 476–480. 4 indexed citations
13.
Cates, Marshall E., et al.. (2012). Pharmacy students' attitudes toward mental illness at the beginning and end of the professional curriculum. Currents in Pharmacy Teaching and Learning. 4(2). 132–136. 9 indexed citations
14.
Jackson, Cherry W., Marshall E. Cates, & Raymond A. Lorenz. (2010). Pharmacotherapy of Eating Disorders. Nutrition in Clinical Practice. 25(2). 143–159. 15 indexed citations
15.
Cates, Marshall E., et al.. (2009). Metabolic Consequences of Using Low-Dose Quetiapine for Insomnia in Psychiatric Patients. Community Mental Health Journal. 45(4). 251–254. 45 indexed citations
16.
Cates, Marshall E., et al.. (2008). Faculty Attitudes and Scholarly Productivity Resulting From a Seminar Course. American Journal of Pharmaceutical Education. 72(1). 8–8. 6 indexed citations
17.
Cates, Marshall E., et al.. (2007). Mental Health and Psychiatric Pharmacy Instruction in US Colleges and Schools of Pharmacy. American Journal of Pharmaceutical Education. 71(1). 4–4. 41 indexed citations
18.
Davis, Lori L., et al.. (2005). Divalproex for the treatment of posttraumatic stress disorder: a retrospective chart review. International Journal of Psychiatry in Clinical Practice. 9(4). 278–283. 8 indexed citations
19.
Davis, Lori L., et al.. (2004). Divalproex sodium in the treatment of adults with bipolar disorder. Expert Review of Neurotherapeutics. 4(3). 349–362. 6 indexed citations
20.
Cates, Marshall E.. (2001). Selecting Antidepressant Therapy for Patients with Major Depression. American Journal of Pharmaceutical Education. 65(2). 190–194. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie A. Dopheide Breakdown of academic impact, for papers by Joanne Rodda Breakdown of academic impact, for papers by Heidi J. Wehring Breakdown of academic impact, for papers by J. Donoghue Breakdown of academic impact, for papers by Christophe Arbus Breakdown of academic impact, for papers by Mónica Martínez‐Cengotitabengoa Breakdown of academic impact, for papers by Carmine Munizza Breakdown of academic impact, for papers by Hans Gutzmann Breakdown of academic impact, for papers by Zunera Khan Breakdown of academic impact, for papers by Michael D. Jibson
Rankless by CCL
2026